Cargando…
AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer
The lack of effective screening and successful treatment contributes to high ovarian cancer mortality, making it the second most common cause of gynecologic cancer death. Development of chemoresistance in up to 75% of patients is the cause of a poor treatment response and reduced survival. Therefore...
Autores principales: | Ardizzoia, Alessandra, Jemma, Andrea, Redaelli, Serena, Silva, Marco, Bentivegna, Angela, Lavitrano, Marialuisa, Conconi, Donatella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380391/ https://www.ncbi.nlm.nih.gov/pubmed/37511212 http://dx.doi.org/10.3390/ijms241411455 |
Ejemplares similares
-
AhRR methylation contributes to disease progression in urothelial bladder cancer
por: El-Haddad, Nataly W., et al.
Publicado: (2022) -
Analysis of copy number alterations in bladder cancer stem cells revealed a prognostic role of LRP1B
por: Conconi, Donatella, et al.
Publicado: (2022) -
Dietary AhR Ligands Regulate AhRR Expression in Intestinal Immune Cells and Intestinal Microbiota Composition
por: Schanz, Oliver, et al.
Publicado: (2020) -
Transgenic Overexpression of Aryl Hydrocarbon Receptor Repressor (AhRR) and AhR-Mediated Induction of CYP1A1, Cytokines, and Acute Toxicity
por: Vogel, Christoph F.A., et al.
Publicado: (2016) -
Using Copy Number Alterations to Identify New Therapeutic Targets for Bladder Carcinoma
por: Conconi, Donatella, et al.
Publicado: (2016)